文献速递姑息放疗与转移瘤放疗物理与技术中枢神经肿瘤放疗

脊柱转移瘤再程立体定向放疗的计划流程:高容量多学科脊柱肿瘤项目的SOaR2方案

Reirradiation With Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure From a High-Volume Multidisciplinary Spine Oncology Program (SOaR2).
PubMed 文献 · Pract Radiat Oncol · 2025-12-11

该研究旨在建立系统化的脊柱再程立体定向放疗计划协议,优先保障患者安全并最大化肿瘤剂量。患者经多学科脊柱肿瘤委员会确认复发或进展后,由放疗科和神经外科门诊评估,合适者进入CT/MRI模拟定位,并启动物理专项路径,由两名物理师独立验证MRI与计划CT的融合。通过生成物理剂量、EQD2 α/β=2和α/β=3的计划评估危及器官既往剂量,并制定复合计划评估累积剂量。治疗采用6自由度床及锥形束CT,对配准偏移>2 mm或1°进行评估,必要时物理师进行离线计划适配分析。该协议为脊柱再程SBRT提供了系统化方法,支持安全治疗。

要点

  • 多学科肿瘤委员会确认复发/进展后启动再程SBRT计划流程。
  • 物理专项路径融合MRI与计划CT,由两名物理师独立验证。
  • 生成物理剂量及EQD2 α/β=2、α/β=3计划评估既往和累积剂量。

核心结论

  • 该协议建立了脊柱再程SBRT的系统化计划和实施方法,支持安全治疗。

研究设计与样本

  • 单中心高容量多学科脊柱肿瘤项目的计划流程描述,患者经肿瘤委员会和门诊评估后进入模拟定位和物理专项路径。

主要发现

  • 通过融合MRI和计划CT并独立验证,显示既往剂量于新影像,生成物理剂量、EQD2 α/β=2和α/β=3计划评估危及器官。
  • 创建当前疗程与所有既往疗程的计划总和及复合计划,评估靶区和危及器官的当前与累积剂量。
  • 治疗采用6自由度床和锥形束CT,对配准偏移>2 mm或1°进行评估,必要时物理师进行离线计划适配分析。

关键数值与推荐

  • 危及器官约束以EQD2为基础目标,转换为当前计划的物理剂量。
  • 配准偏移>2 mm或1°需评估,物理师可进行离线计划适配分析。

临床怎么用

  • 再程脊柱SBRT应通过多学科团队确认复发/进展,并启动物理专项路径融合既往剂量。
  • 计划时生成物理剂量和EQD2 α/β=2、α/β=3计划评估累积剂量,优先尊重危及器官约束。
  • 治疗中利用锥形束CT监测偏移,对>2 mm或1°的偏移评估并考虑离线计划适配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We sought to develop a systematic spine reirradiation planning protocol prioritizing patient safety and maximizing tumor dose delivery. Patients were presented at a Multidisciplinary Spine Oncology Tumor Board to confirm suspicion for recurrent or progressive malignancy and were evaluated in the clinic by the Department of Radiation Oncology and Neurosurgery. Suitable patients proceeded to computed tomography (CT)/magnetic resonance imaging scan simulation. A dedicated physics pathway was activated with the fusion of the magnetic resonance imaging scan and planned CT scan, verified independently by 2 physicists. The prior radiation data set was registered to the new imaging data set, and the prior dose was displayed on the new imaging data set. Physical dose, equivalent dose in 2 Gy fractions (EQD2) α/β = 2, and EQD2 α/β = 3 plans were generated to evaluate prior dose to organs at risk (OARs). Target volumes were defined on the new data set. Dose, fractionation, and OAR constraints were prescribed by the treating physician in accordance with the literature, with priority given to respecting OARs. The constraints were stipulated as EQD2-based objectives and converted to physical doses for the current plan. A plan-sum of the current course and all prior courses was created and displayed on the new imaging data set for evaluation. Composite, EQD2 α/β = 2, and EQD2 α/β = 3 plans were generated to evaluate current and cumulative dose to the target and OARs. Treatment was delivered on a 6°-of-freedom couch with pretreatment, midtreatment, and posttreatment cone beam CT scan imaging. Registration-based shifts > 2 mm or 1° were evaluated. When requested, physicists performed quantitative analysis of dosimetric impact using a forward calculation of the plan on the planning image with the treatment shifts applied to determine whether an offline plan adaptation is necessary. Our protocol contributed to the growing literature on spinal reirradiation with stereotactic body radiation therapy and enabled safe treatment in cases of incidental spinal cord exposure. We developed a systematic approach to planning and delivering spinal reirradiation with stereotactic body radiation therapy.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Messing I, Alexander D, Scheuermann R, et al. Reirradiation With Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure From a High-Volume Multidisciplinary Spine Oncology Program (SOaR2). Pract Radiat Oncol. 2025. PMID: 41389998. doi:10.1016/j.prro.2025.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。